Latest News - Psivida

Tuesday, April 14, 2015

pSivida Reports Iluvien for DME Approved in Poland

pSivida Corp. announced that the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland has granted marketing authorization to Iluvien for the treatment of visi…

Read the full story

Thursday, March 26, 2015

pSivida Completes Targeted Enrollment of Phase 3 Trial of Medidur for Posterior Uveitis

pSivida announced the completion of the originally targeted enrollment of 120 patients in its pivotal phase 3 clinical trial of Medidur for the treatment of posterior uveitis, according to a company n…

Read the full story

Tuesday, February 17, 2015

pSivida Announces US Shipments of Iluvien for DME to Start February 23

pSivida Corp. announced that initial nationwide shipments of Iluvien for diabetic macular edema (DME) are scheduled to begin in the United States on February 23, according to a company news release. …

Read the full story

Tuesday, January 27, 2015

pSivida Reports Iluvien Receives Marketing Authorization in Two More EU Countries

pSivida Corp. announced that Finland and Luxembourg have granted marketing authorization to Iluvien for the treatment of vision impairment associated with chronic diabetic macular edema (DME) consider…

Read the full story